Abstract 3133: A pharmacogenetic interaction analysis of second-line chemotherapy with bevacizumab in metastatic colorectal cancer patients: Results from the randomized BEBYP trial
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: University of Pisa, National Research Council
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148857155
Cites:
Cited by:
Related to: